Lithium Therapy Market By Rerports And Data
                     Lithium Therapy Market To Reach 
USD 128.6 Million By 2027
www.reportsanddat
a.com
       Market  Summary
The growing prevalence of bipolar disorder is a significant factor 
influencing market demand.
Market Size – USD 103.9 Million in 2018, Market Growth - CAGR 
of 2.3%, Market Trends – Growing geriatric population
The global lithium therapy market is expected to reach USD 
128.6 Million by 2027, according to a new report by Reports and 
Data. Lithium Therapy is used as an antipsychotic drug for 
treating bipolar disorder. Sometimes, it may be utilized in other 
disorders to supplement an antidepressant that is unable to 
treat depression effectively.
            M  a Orkuetr  S Aumpmparroyach
The growing prevalence of bipolar disorder is a significant factor in influencing the market growth. Bipolar 
disorder is a neurobiological disorder of the brain that currently impacts nearly 2.3 million people in the 
U.S. or about 1.0% of the total U.S. population. Suicide is the foremost reason for premature death amongst 
people who have bipolar disorder, with 15.0% to 17.0% committing suicide, owing to negative symptoms 
that arise from an untreated illness. Individuals who have bipolar disorder were over 25 times more likely 
to experience panic disorder and around ten times more likely to experience obsessive-compulsive 
disorder as compared to people in the general population with the condition.
The growing geriatric population is likely to boost the market demand in the forecast period. According to 
a study, bipolar disorder exists in 6.0% of geriatric outpatient appointments, 8.0%–10.0% of geriatric 
inpatient admissions, 3.0% of geriatric people admitted in nursing homes, and 17% of geriatric patients 
referred to psychiatric emergency departments. Hence, the worldwide rise in the aging population will be 
directly proportional to the number of older adults with the condition.
Request for a sample of this research report @ https://www.reportsanddata.com/sample-enquiry-form/2586
       M   a r kOeut  Sru Ampmparyoach
Key participants include Pfizer, Alkem, Sun Pharma, Apotek Corp., Glenmark Generics, Intas, Taurus Labs, 
GlaxoSmithKline, Noven Pharmaceuticals, and Cardinal Health, among others.
For the purpose of this report, Reports and Data have segmented the global lithium therapy market on 
the basis of product type, dosage form, distribution channel, and region:
Product Type Outlook (Revenue, USD Million; 2016-2027)
• Generic
• Branded
Dosage Form Outlook (Revenue, USD Million; 2016-2027)
• Capsule
• Solution
• Tablet, Extended Release
• Tablet
       M   a r kOeut  Sru Ampmparyoach
Distribution Channel Outlook (Revenue, USD Million; 2016-2027)
• Hospital & Clinic Pharmacies
• Online-Retail Pharmacies
• Offline-Retail Pharmacies
Regional Outlook (Revenue, USD Million; 2016-2027)
• North America
• Europe
• Asia Pacific
• Latin America
• MEA
View press release for more information @ https://
www.globenewswire.com/news-release/2020/03/09/1997330/0/en/Lithium-Therapy-Market-To-Reach-US
D-128-6-Million-By-2027-Reports-and-Data.html
About Us
   A  b  oOuutr U Aspproach
Reports and Data is a market research and consulting company that provides syndicated research 
reports, customized research reports, and consulting services. Our solutions purely focus on your 
purpose to locate, target and analyze consumer behavior shifts across demographics, across industries 
and help client’s make a smarter business decision. We offer market intelligence studies ensuring 
relevant and fact-based research across a multiple industries including Healthcare, Technology, 
Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are 
aware about the latest trends existent in the market. Reports and Data has a strong base of 
experienced analysts from varied areas of expertise.
Contact Us:
John Watson
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: [email protected]